Biden administration won’t lower seniors’ Medicare premiums this year, despite changes to coverage of new Alzheimer’s drug
WASHINGTON — The Biden administration on Friday said it will not lower Medicare premiums for seniors this year, even though their costs spiked based based on inflated financial projections for the beleaguered Alzheimer’s drug, Aduhelm.
Health and Human Services Secretary Xavier Becerra in January publicly announced he was ordering Medicare to consider dropping seniors’ premiums in the middle of this year, which would have been an unprecedented move. But the administration decided against a change due to “legal and operational hurdles,” the department said Friday afternoon.
